DiNonA Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 22

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $143M

  • Investors
  • 1

DiNonA General Information

Description

Developer of an antibody drug therapeutics based in Seoul, South Korea. The company specializes in researching and developing antibody related therapeutics and diagnostic reagents.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Asan institute for Life Sciences
  • 11th Floor, 88, Olympic-ro 43-gil Songpa-gu
  • Seoul
  • South Korea
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Asan institute for Life Sciences
  • 11th Floor, 88, Olympic-ro 43-gil Songpa-gu
  • Seoul
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DiNonA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 27-Oct-2021 $143M Completed Generating Revenue
5. PIPE 30-Oct-2020 Completed Generating Revenue
4. PIPE 31-Jul-2020 Completed Generating Revenue
3. IPO 08-May-2018 Completed Generating Revenue
2. Later Stage VC 01-Jan-2015 $3.62M $4.51M Completed Startup
1. Later Stage VC 01-Mar-2012 $890K $890K Completed Startup
To view DiNonA’s complete valuation and funding history, request access »

DiNonA Patents

DiNonA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022518363-A Antibodies that specifically bind to icam-1 and their uses Active 31-Dec-2018
WO-2020141869-A1 Antibody specifically binding to icam-1 and use thereof Inactive 31-Dec-2018
JP-2021523193-A Prophylactic and therapeutic uses for bone marrow-derived inhibitory cell-related diseases Active 14-May-2018
CA-3099968-A1 Use for preventing and treating myeloid-derived suppressor cell-related diseases Inactive 14-May-2018
WO-2019221574-A1 Use for preventing and treating myeloid-derived suppressor cell-related diseases Inactive 14-May-2018 A61K40/42
To view DiNonA’s complete patent history, request access »

DiNonA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DiNonA Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
DSC Investment Venture Capital Minority
HB Investment Venture Capital Minority
ID Ventures (South Korea) Venture Capital Minority
IMM Investment Asset Manager Minority
InterVest Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

DiNonA Investments (2)

DiNonA’s most recent deal was a PIPE with Hwail Pharmaceutical for . The deal was made on 29-Sep-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hwail Pharmaceutical 29-Sep-2020 PIPE Other Pharmaceuticals and Biotechnology
Hwail Pharmaceutical 18-Sep-2020 Secondary Transaction - Private Other Pharmaceuticals and Biotechnology
To view DiNonA’s complete investments history, request access »

DiNonA FAQs

  • When was DiNonA founded?

    DiNonA was founded in 1999.

  • Where is DiNonA headquartered?

    DiNonA is headquartered in Seoul, South Korea.

  • What is the size of DiNonA?

    DiNonA has 22 total employees.

  • What industry is DiNonA in?

    DiNonA’s primary industry is Biotechnology.

  • Is DiNonA a private or public company?

    DiNonA is a Private company.

  • What is the current valuation of DiNonA?

    The current valuation of DiNonA is .

  • What is DiNonA’s current revenue?

    The current revenue for DiNonA is .

  • How much funding has DiNonA raised over time?

    DiNonA has raised $7.9M.

  • Who are DiNonA’s investors?

    DSC Investment, HB Investment, ID Ventures (South Korea), IMM Investment, and InterVest are 5 of 7 investors who have invested in DiNonA.

  • When was DiNonA acquired?

    DiNonA was acquired on 27-Oct-2021.

  • Who acquired DiNonA?

    DiNonA was acquired by Ecovolt (South Korea) and Kumho HT.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process